7187379870

Research & Reviews in BioSciences
ISSN 0974-7532

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Trastuzumab

 Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal counter acting agent used to treat breast cancer and stomach cancer. It is explicitly utilized for cancer that is HER2 receptor positive. It might be utilized without anyone else or along with other chemotherapy drug. Trastuzumab is utilized to treat metastatic (spread) breast cancer. As a major aspect of chemotherapy routine for adjuvant treatment of lymph-hub positive, HER2/neu protein positive breast cancer. Treatment of gastric (stomach) cancer. Trastuzumab is a focused on cancer sedate and is additionally known by its image name, Herceptin, Herzuma and Ontruzant. It is a treatment for cancers that have a lot of a protein called human epidermal development factor receptor 2 (HER2, for example, early breast cancer. propelled breast cancer.

High Impact List of Articles

Relevant Topics in General Science

Awards Nomination

Table of Contents

Google Scholar citation report
Citations : 627

Research & Reviews in BioSciences received 627 citations as per Google Scholar report

Citation image

Indexed In

  • Google Scholar
  • Open J Gate
  • China National Knowledge Infrastructure (CNKI)
  • Cosmos IF
  • Directory of Research Journal Indexing (DRJI)
  • Scholarsteer
  • Secret Search Engine Labs
  • Euro Pub
  • ICMJE

View More

For Authors

For Librarians

Open Access Journals